VIRTUS: An Evaluation of the Vici™ Venous Stent System in Patients With Chronic Iliofemoral Venous Outflow Obstruction
Public ClinicalTrials.gov record NCT02112877. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
VIRTUS Safety and Efficacy of the Veniti Vici™ Venous Stent System (Veniti, Inc.) When Used to Treat Clinically Significant Chronic Non-malignant Obstruction of the Iliofemoral Venous Segment
Study identification
- NCT ID
- NCT02112877
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- Boston Scientific Corporation
- Industry
- Enrollment
- 200 participants
Conditions and interventions
Conditions
Interventions
- Veniti Vici™ Venous Stent System Device
Device
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 25, 2014
- Primary completion
- Dec 4, 2017
- Completion
- Dec 17, 2020
- Last update posted
- Apr 14, 2021
2014 – 2020
United States locations
- U.S. sites
- 16
- U.S. states
- 13
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Abrazo Arizona Heart Hospital | Phoenix | Arizona | 85016 | — |
| Healthfinity PLCC | Scottsdale | Arizona | 85254 | — |
| Arkansas Site Management Services, LLC | Little Rock | Arkansas | 72211 | — |
| St. Joseph Hospital | Orange | California | 92868 | — |
| Radiology Imaging Associates | Englewood | Colorado | 80112 | — |
| Vascular Breakthroughs | Darien | Connecticut | 06820 | — |
| Midwest Cardiovascular Foundation | Davenport | Iowa | 52803 | — |
| Imperial Health, LLP | Lake Charles | Louisiana | 70601 | — |
| Michigan Vascular Center | Flint | Michigan | 48507 | — |
| NYU School of Medicine | New York | New York | 10016 | — |
| Icahn School of Medicine at Mount Sinai | New York | New York | 10029 | — |
| New York Presbyterian Hospital/Cornell University | New York | New York | 10065 | — |
| The University of North Carolina at Chapel Hill | Chapel Hill | North Carolina | 27599 | — |
| Dr. Ediberto Soto-Cora | El Paso | Texas | 79925 | — |
| Sentara Vascular Specialists | Norfolk | Virginia | 23507 | — |
| University of Washington Medical Center | Seattle | Washington | 98195 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 8 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02112877, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 14, 2021 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02112877 live on ClinicalTrials.gov.